STOCK TITAN
  1. Home
  2. Sec-filings
  3. BBIO
  4. [144] BridgeBio Pharma, Inc. SEC Filing

BridgeBio (NASDAQ: BBIO) insider plans $2.8M stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BridgeBio Pharma, Inc. (BBIO) received a notice that Neil Kumar intends to sell common stock under Rule 144. The filing lists 34,980 shares of common stock held through Morgan Stanley Smith Barney, with a reported value of $2,794,552.20, against 195,487,474 shares outstanding as of August 18, 2026. It also details prior Rule 10b5-1 plan sales over the past three months by Kumar and related trusts.

Positive

  • None.

Negative

  • None.
Shares to be sold 34,980 shares Common stock listed in Rule 144 notice held via Morgan Stanley Smith Barney LLC
Value of shares to be sold $2,794,552.20 Reported value for 34,980 BridgeBio Pharma common shares in Rule 144 section
Shares outstanding 195,487,474 shares BridgeBio Pharma common shares outstanding as of August 18, 2026
10b5-1 sale 1 20,000 shares Common shares sold June 5, 2026 by Kumar Haldea Revocable Trust under 10b5-1 plan
Proceeds from 10b5-1 sale 1 $1,357,538.00 Dollar amount for 20,000-share 10b5-1 sale on June 5, 2026
10b5-1 sale by Neil Kumar 26,103 shares Common shares sold May 21, 2026 by Neil Kumar under 10b5-1 plan
Proceeds from Neil Kumar 10b5-1 sale $1,812,521.84 Dollar amount for 26,103-share sale on May 21, 2026
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Units financial
"Common | 08/16/2026 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 regulatory
"10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Revocable Trust financial
"10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Irrevocable Trust financial
"KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What does the Form 144 filing by BBIO insider Neil Kumar disclose?
The filing discloses Neil Kumar’s intent to sell 34,980 shares of BridgeBio Pharma common stock under Rule 144, along with a record of recent Rule 10b5-1 plan sales over the prior three months.

How many BBIO shares does Neil Kumar plan to sell under this Form 144?
Neil Kumar indicates a planned sale of 34,980 shares of BridgeBio Pharma common stock, held through Morgan Stanley Smith Barney LLC Executive Financial Services, as reported in the Rule 144 notice.

What is the reported value of the BBIO shares subject to Neil Kumar’s planned Rule 144 sale?
The Rule 144 notice reports a value of $2,794,552.20 for the 34,980 shares of BridgeBio Pharma common stock listed for potential sale through Morgan Stanley Smith Barney LLC.

How many BridgeBio Pharma (BBIO) shares were outstanding as referenced in this Form 144?
The notice references 195,487,474 shares outstanding of BridgeBio Pharma common stock as of August 18, 2026, providing a baseline figure separate from the shares that may be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR